Affiliation:
1. School of Optometry and Vision Science, University of New South Wales, Sydney, NSW 2052, Australia
Abstract
The global rise in antibiotic resistance in bacteria poses a major challenge in treating infectious diseases. Polymyxins (e.g., polymyxin B and colistin) are last-resort antibiotics against resistant Gram-negative bacteria, but the effectiveness of polymyxins is decreasing due to widespread resistance among clinical isolates. The aim of this literature review was to decipher the evolving mechanisms of resistance to polymyxins among pathogens of clinical significance. We deciphered the molecular determinants of polymyxin resistance, including distinct intrinsic molecular pathways of resistance as well as evolutionary characteristics of mobile colistin resistance. Among clinical isolates, Acinetobacter stains represent a diversified evolution of resistance, with distinct molecular mechanisms of intrinsic resistance including naxD, lpxACD, and stkR gene deletion. On the other hand, Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa are usually resistant via the PhoP-PhoQ and PmrA-PmrB pathways. Molecular evolutionary analysis of mcr genes was undertaken to show relative relatedness across the ten main lineages. Understanding the molecular determinants of resistance to polymyxins may help develop suitable and effective methods for detecting polymyxin resistance determinants and the development of novel antimicrobial molecules.
Subject
Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Pharmacology, Toxicology and Pharmaceutics,Biochemistry,Microbiology
Reference189 articles.
1. Colistin and its role in the Era of antibiotic resistance: An extended review (2000–2019);Zhong;Emerg. Microbes Infect.,2020
2. Trebosc, V., Gartenmann, S., Tötzl, M., Lucchini, V., Schellhorn, B., Pieren, M., Lociuro, S., Gitzinger, M., Tigges, M., and Bumann, D. (2019). Dissecting colistin resistance mechanisms in extensively drug-resistant Acinetobacter baumannii clinical isolates. mBio, 10.
3. Polymyxin: A new chemotherapeutic agent;Stansly;Bull. Johns Hopkins Hosp.,1947
4. Vaara, M. (2019). Polymyxins and their potential next generation as therapeutic antibiotics. Front. Microbiol., 10.
5. A new antibiotic ‘colistin’ produced by spore-forming soil bacteria;Koyama;J. Antibiot.,1950
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献